Vanda Pharmaceuticals (VNDA) Cash & Current Investments: 2010-2025
Historic Cash & Current Investments for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Sep 2025 value amounting to $293.8 million.
- Vanda Pharmaceuticals' Cash & Current Investments fell 21.93% to $293.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 13.68%. This contributed to the annual value of $374.6 million for FY2024, which is 3.51% down from last year.
- Latest data reveals that Vanda Pharmaceuticals reported Cash & Current Investments of $293.8 million as of Q3 2025, which was down 9.77% from $325.6 million recorded in Q2 2025.
- Vanda Pharmaceuticals' 5-year Cash & Current Investments high stood at $501.5 million for Q1 2023, and its period low was $293.8 million during Q3 2025.
- In the last 3 years, Vanda Pharmaceuticals' Cash & Current Investments had a median value of $387.7 million in 2024 and averaged $396.5 million.
- Per our database at Business Quant, Vanda Pharmaceuticals' Cash & Current Investments increased by 21.08% in 2021 and then dropped by 23.19% in 2024.
- Quarterly analysis of 5 years shows Vanda Pharmaceuticals' Cash & Current Investments stood at $432.8 million in 2021, then increased by 7.87% to $466.9 million in 2022, then declined by 16.83% to $388.3 million in 2023, then dropped by 3.51% to $374.6 million in 2024, then dropped by 21.93% to $293.8 million in 2025.
- Its Cash & Current Investments stands at $293.8 million for Q3 2025, versus $325.6 million for Q2 2025 and $340.9 million for Q1 2025.